View Author
plaque disease patient circulation study factor protein heart concentration plasma event university death atherosclerosi blood hsp 27 risk factors artery atherosclerotic medicine syndrome shock center infarction table cardiology thrombosis department research association technique vulnerability marker control artery disease coll cardiol school rupture inflammation women atherosclerotic plaques intravascular assessment imaging institute baseline risk assessment strategies myocardium hospital cardiol noninvasive antibody level variable naghavi future hsp 27 concentration heat shock proteins division model lesion figure method cholesterol resonance imaging serum laboratory fuster v health culprit intravascular ultrasound development stenosi ultrasound characteristic j cardiol plaque rupture baseline characteristics thrombu detection
3 Most Recent Publications
|
Plasma concentration of heat shock protein 27 and risk of cardiovascular disease: A prospective, nested case-control study
(Article)
Kardys, I. Rifai, N. Meilhac, O. Michel, J.B. Martin-Ventura, J.L. Buring, J.E. Libby, P. Ridker, P.M. |
2008-01-01
|
|
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.
(Article)
Naghavi, M. Libby, P. Fayad, Z. Stone, P.H. Waxman, S. Raggi, P. Madjid, M. Zarrabi, A. Burke, A.E. Yuan, C. Fitzgerald, P.J. Siscovick, D.S. Falk, E. Korte, C.L. de Aikawa, M. Juhani Airaksinen, K.E. Assmann, G. Becker, C.R. Chesebro, J.H. Farb, A. Galis, Z.S. Jackson, C. Jang, I.K. Casscells, S.W. Koenig, W. Lodder, R.A. March, K. Demirovic, J. Navab, M. Priori, S.G. Rekhter, M.D. Bahr, R. Grundy, S.M. Mehran, R. Litovsky, S. Colombo, A. Boerwinkle, E. Ballantyne, C. Insull Jr, W. Schwartz, R.S. Vogel, R. Serruys, P.W.J.C. Hansson, G.K. Faxon, D.P. Kaul, S. Rumberger, J. Drexler, H. Greenland, P. Muller, J.E. Virmani, R. Ridker, P.M. Zipes, D.P. Shah, P.K. Willerson, J.T. Badimon, J.J. Stefanadis, C. Moreno, P.R. Pasterkamp, G. |
2003-10-14
|
|
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.
(Article)
Naghavi, M. Libby, P. Fayad, Z. Stone, P.H. Waxman, S. Raggi, P. Madjid, M. Zarrabi, A. Burke, A.E. Yuan, C. Fitzgerald, P.J. Siscovick, D.S. Falk, E. Korte, C.L. de Aikawa, M. Juhani Airaksinen, K.E. Assmann, G. Becker, C.R. Chesebro, J.H. Farb, A. Galis, Z.S. Jackson, C. Jang, I.K. Casscells, S.W. Koenig, W. Lodder, R.A. March, K. Demirovic, J. Navab, M. Priori, S.G. Rekhter, M.D. Bahr, R. Grundy, S.M. Mehran, R. Litovsky, S. Colombo, A. Boerwinkle, E. Ballantyne, C. Insull Jr, W. Schwartz, R.S. Vogel, R. Serruys, P.W.J.C. Hansson, G.K. Faxon, D.P. Kaul, S. Rumberger, J. Drexler, H. Greenland, P. Muller, J.E. Virmani, R. Ridker, P.M. Zipes, D.P. Shah, P.K. Willerson, J.T. Badimon, J.J. Stefanadis, C. Moreno, P.R. Pasterkamp, G. |
2003-10-07
|
